Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

Balance Sheet: Liabilities and Stockholders’ Equity 

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

CVS Health Corp., consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Accounts payable 15,892 14,897 14,838 12,544 11,138
Pharmacy claims and discounts payable 24,166 22,874 19,423 17,330 15,795
Health care costs payable 15,064 12,049 10,406 8,808 7,936
Accrued expenses and other current liabilities 20,810 23,515 20,245 21,971 18,513
Other insurance liabilities 1,183 1,141 1,140 1,303 1,557
Current portion of operating lease liabilities 1,751 1,741 1,678 1,646 1,638
Short-term debt 2,119 200
Current portion of long-term debt 3,624 2,772 1,778 4,205 5,440
Liabilities held for sale 228
Current liabilities 84,609 79,189 69,736 67,807 62,017
Long-term operating lease liabilities 14,899 16,034 16,800 18,177 18,757
Long-term debt, excluding current portion 60,527 58,638 50,476 51,971 59,207
Deferred income taxes 3,806 4,311 3,880 6,270 6,794
Separate accounts liabilities 3,311 3,250 3,228 5,087 4,881
Other long-term insurance liabilities 4,902 5,459 6,108 6,402 7,007
Other long-term liabilities 5,431 6,211 6,732 1,904 2,351
Long-term liabilities 92,876 93,903 87,224 89,811 98,997
Total liabilities 177,485 173,092 156,960 157,618 161,014
Preferred stock, par value $0.01; none issued or outstanding
Common stock, par value $0.01, and capital surplus 49,661 48,992 48,193 47,377 46,513
Treasury stock, at cost (36,818) (33,838) (31,858) (28,173) (28,178)
Retained earnings 62,837 61,604 56,145 54,906 49,640
Accumulated other comprehensive income (loss) (120) (297) (1,465) 965 1,414
Total CVS Health shareholders’ equity 75,560 76,461 71,015 75,075 69,389
Noncontrolling interests 170 175 300 306 312
Total shareholders’ equity 75,730 76,636 71,315 75,381 69,701
Total liabilities and shareholders’ equity 253,215 249,728 228,275 232,999 230,715

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. CVS Health Corp. current liabilities increased from 2022 to 2023 and from 2023 to 2024.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. CVS Health Corp. long-term liabilities increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. CVS Health Corp. total liabilities increased from 2022 to 2023 and from 2023 to 2024.
Total CVS Health shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. CVS Health Corp. total CVS Health shareholders’ equity increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.